NEURAXIS, INC. (NRXS) Gross Margin
- Gross margin · 12 months: Value 85.56%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 85.56% | Gross profit / revenue. Period ending 2026-06-30. $4.55M ÷ $5.32M × 100 ≈ 85.56% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 4.55M USD | Gross Profit |
| Revenue | 5.32M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 767.74K USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $4.55M | $5.32M | $767.74K | 85.56% |
| 2026-03-31 | $3.64M | $4.28M | $641.81K | 85.01% |
| 2025-12-31 | $3.01M | $3.57M | $562.92K | 84.23% |
| 2025-09-30 | $2.84M | $3.36M | $526.32K | 84.35% |
| 2025-06-30 | $2.72M | $3.22M | $499.58K | 84.47% |
| 2025-03-31 | $2.51M | $2.93M | $426.40K | 85.47% |
| 2024-12-31 | $2.32M | $2.69M | $362.00K | 86.52% |
| 2024-09-30 | $2.13M | $2.46M | $329.29K | 86.59% |
| 2024-06-30 | $1.98M | $2.27M | $288.17K | 87.29% |
| 2024-03-31 | $2.02M | $2.30M | $282.53K | 87.72% |
| 2023-12-31 | $2.16M | $2.46M | $303.35K | 87.67% |
| 2023-09-30 | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) |
| 2022-12-31 | $2.39M | $2.68M | $297.06K | 88.94% |
| 2022-09-30 | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |